183 related articles for article (PubMed ID: 22135700)
1. Closure of an open wound associated with bisphosphonate-related osteonecrosis of the jaw in a breast cancer patient.
Soolari N; Soolari A
Open Dent J; 2011; 5():163-7. PubMed ID: 22135700
[TBL] [Abstract][Full Text] [Related]
2. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
[TBL] [Abstract][Full Text] [Related]
3. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O; Peter JU
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012432. PubMed ID: 35866376
[TBL] [Abstract][Full Text] [Related]
4. Phosphate buffer-stabilized 0.1% chlorine dioxide oral rinse for managing medication-related osteonecrosis of the jaw.
Myneni Venkatasatya SR; Wang HH; Alluri S; Ciancio SG
Am J Dent; 2017 Dec; 30(6):350-352. PubMed ID: 29251459
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice.
Kuroshima S; Sasaki M; Nakajima K; Tamaki S; Hayano H; Sawase T
Bone; 2018 Jul; 112():177-186. PubMed ID: 29729428
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Grewal VS; Fayans EP
Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
[TBL] [Abstract][Full Text] [Related]
7. Clinical application of double-layer soft tissue closure technology based on pedicled buccal fat pad in repairing maxillary defects after medication-related osteonecrosis of jaw surgery.
Guo Y; Zhao N; Wang D; Wang Y; Guo C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2022 Jan; 40(1):61-67. PubMed ID: 38596994
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of 24 cases of bisphosphonate-related osteonecrosis of the jaw].
Guo Y; Wang D; An J; Peng X; Cai Z; Guo C
Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Sep; 49(9):517-20. PubMed ID: 25476210
[TBL] [Abstract][Full Text] [Related]
9. Observational study of the bisphosphonate-related osteonecrosis of jaws.
Lungu AE; Lazar MA; Tonea A; Rotaru H; Roman RC; Badea ME
Clujul Med; 2018; 91(2):209-215. PubMed ID: 29785160
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
11. A case of bisphosphonate-related osteonecrosis of the maxilla with orbital cellulitis.
Tajima S; Matsuno H; Matsumoto F; Ikeda K
Ear Nose Throat J; 2022 Mar; ():1455613221086028. PubMed ID: 35357247
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: Radiologic aspects.
Wasserzug O; Kaffe I; Lazarovici TS; Weissman T; Yahalom R; Fliss DM; Yarom N
Am J Rhinol Allergy; 2017 Jan; 31(1):36-39. PubMed ID: 28234151
[TBL] [Abstract][Full Text] [Related]
13. Osteonecrosis of the jaw after implant surgery in patients treated with bisphosphonates--a presentation of six consecutive cases.
Tam Y; Kar K; Nowzari H; Cha HS; Ahn KM
Clin Implant Dent Relat Res; 2014 Oct; 16(5):751-61. PubMed ID: 23445465
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate-related osteonecrosis of the jaw in a multiple myeloma patient: A case report with characteristic radiographic features.
Lee BD; Park MR; Kwon KH
Imaging Sci Dent; 2015 Sep; 45(3):199-203. PubMed ID: 26389064
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
Marx RE; Sawatari Y; Fortin M; Broumand V
J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
[TBL] [Abstract][Full Text] [Related]
16. The care and management of bisphosphonate--associated osteonecrosis of the jaw in the patient with multiple myeloma: a case study.
Teah MJ; Syme SL; Scheper M; Weikel DS
J Dent Hyg; 2013 Aug; 87(4):181-7. PubMed ID: 23986411
[TBL] [Abstract][Full Text] [Related]
17. Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis.
Sarin J; DeRossi SS; Akintoye SO
Oral Dis; 2008 Apr; 14(3):277-85. PubMed ID: 18336375
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates.
Farrugia MC; Summerlin DJ; Krowiak E; Huntley T; Freeman S; Borrowdale R; Tomich C
Laryngoscope; 2006 Jan; 116(1):115-20. PubMed ID: 16481822
[TBL] [Abstract][Full Text] [Related]
19. A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
Hasegawa T; Kawakita A; Ueda N; Funahara R; Tachibana A; Kobayashi M; Kondou E; Takeda D; Kojima Y; Sato S; Yanamoto S; Komatsubara H; Umeda M; Kirita T; Kurita H; Shibuya Y; Komori T;
Osteoporos Int; 2017 Aug; 28(8):2465-2473. PubMed ID: 28451732
[TBL] [Abstract][Full Text] [Related]
20. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
Friedrich RE; Blake FA
Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
